NCT05161013View on ClinicalTrials.gov

A Proof-of-Concept Study Evaluating LINFU™

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

October 1, 2023

Study Completion Date

October 30, 2023

Conditions
Pancreas AdenocarcinomaDysplasia
Interventions
DIAGNOSTIC_TEST

LINFU™

A method to detect pancreatic cancer (ductal adenocarcinoma) using ultrasound technology in those who are at significantly increased risk for developing pancreatic cancer. LINFU™ involves analysis of pancreatic fluid collected.

Trial Locations (1)

34239

Gastroenterology Associates of Sarasota, Sarasota

All Listed Sponsors
lead

Adenocyte, LLC

INDUSTRY

NCT05161013 - A Proof-of-Concept Study Evaluating LINFU™ | Biotech Hunter | Biotech Hunter